Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Accenture
Colorcon
Healthtrust
Moodys
Cerilliant
Daiichi Sankyo
Cantor Fitzgerald
Chinese Patent Office
Argus Health

Generated: January 17, 2018

DrugPatentWatch Database Preview

TAMBOCOR Drug Profile

« Back to Dashboard

Which patents cover Tambocor, and what generic alternatives are available?

Tambocor is a drug marketed by Cnty Line Pharms and is included in one NDA.

The generic ingredient in TAMBOCOR is flecainide acetate. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the flecainide acetate profile page.
Drug patent expirations by year for TAMBOCOR
Pharmacology for TAMBOCOR
Drug ClassAntiarrhythmic
Medical Subject Heading (MeSH) Categories for TAMBOCOR

US Patents and Regulatory Information for TAMBOCOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-003 Jun 3, 1988 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TAMBOCOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985 ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-003 Jun 3, 1988 ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985 ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 ➤ Subscribe ➤ Subscribe
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
QuintilesIMS
Teva
Cerilliant
Boehringer Ingelheim
UBS
Julphar
Citi
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot